IMNM – immunome, inc. (US:NASDAQ)

News

Immunome to Present at 2024 Bank of America Healthcare Conference
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress [Yahoo! Finance]
Immunome Appoints Kinney Horn as Chief Business Officer [Yahoo! Finance]
Immunome Appoints Kinney Horn as Chief Business Officer
Immunome, Inc. (NASDAQ: IMNM) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $24.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com